Table 2. Risk factors affecting mortality in the first 90 days.
| Mortality negative | Mortality positive | p | |||
| n | % | n | % | ||
| Age (year) | 0.475 | ||||
| <65 | 31 | 88.6 | 4 | 100 | |
| >65 | 4 | 11.4 | 0 | 0 | |
| Sex | 0.732 | ||||
| Male | 34 | 971 | 4 | 100 | |
| Female | 1 | 2.9 | 0 | 0 | |
| Side | 0.609 | ||||
| Left | 12 | 34.3 | 2 | 50 | |
| Right | 23 | 65.7 | 2 | 50 | |
| Charlson Comorbidity Index | 0.318 | ||||
| 2 | 20 | 57.1 | 1 | 25 | |
| >2 | 15 | 42.9 | 3 | 75 | |
| Induction treatment | 0.323 | ||||
| CHT | 7 | 20 | 0 | 0 | |
| CHT-RT | 28 | 80 | 4 | 100 | |
| Induction treatment chemotherapy cycles | 0.556 | ||||
| 2 | 10 | 28.6 | 0 | 0 | |
| 4-6 | 25 | 71.4 | 4 | 100 | |
| Radiotherapy dose | 0.279 | ||||
| <60 Gy | 18 | 64.3 | 1 | 25 | |
| >60 Gy | 10 | 35.7 | 3 | 75 | |
| yTNM | 0.179 | ||||
| I | 16 | 45.7 | 0 | 0 | |
| II | 18 | 51.4 | 4 | 100 | |
| III | 1 | 2.9 | 0 | 0 | |
| Resection | 0.099 | ||||
| Lobectomy | 25 | 71.4 | 1 | 25 | |
| Pneumonectomy | 10 | 28.6 | 3 | 75 | |
| Histopathology | 0.792 | ||||
| Adenocarcinoma | 11 | 31.4 | 1 | 25 | |
| SqCC | 24 | 68.6 | 3 | 75 | |
| Adjuvant | 0.556 | ||||
| Negative | 25 | 71.4 | 4 | 100 | |
| Positive | 10 | 28.6 | 0 | 0 | |
| CHT: Chemotherapy; RT: Radiotherapy; Gy: Gray; SqCC: Squamous Cell Carcinoma; yTNM: Tumor, nodes, and metastases after induction therapy. | |||||